A 90‐day preclinical toxicological evaluation in rats of a highly purified and concentrated mulberry leaf extract
Mulberry (genus Morus) leaves have long been used as a human food, especially in Asia, and animal feed. More recently, mulberry leaf extracts have been introduced as a convenient way to consume mulberry for non‐nutritional functional effects. Reducose® 5% is an Morus alba leaf extract that has been...
Uloženo v:
| Vydáno v: | Journal of applied toxicology Ročník 44; číslo 10; s. 1504 - 1517 |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
Wiley Subscription Services, Inc
01.10.2024
|
| Témata: | |
| ISSN: | 0260-437X, 1099-1263, 1099-1263 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Mulberry (genus Morus) leaves have long been used as a human food, especially in Asia, and animal feed. More recently, mulberry leaf extracts have been introduced as a convenient way to consume mulberry for non‐nutritional functional effects. Reducose® 5% is an Morus alba leaf extract that has been highly purified and standardized to a content of 5 ± 0.5% 1‐deoxynojirimycin, a naturally present polyhydroxylated piperidine alkaloid analog of D‐glucose. This extract has previously been evaluated in acute and subacute (28‐day) oral toxicity studies in which no adverse effects of the test item were observed in mice or rats, respectively. Due to continued and growing interest in the extract in multinational markets, we have now further investigated potential toxic effects in subchronic (90‐day) oral toxicity study in male and female Han:WIST rats. The test item was administered at doses of 850, 1700, and 2550 mg/kg bw/day, and did not cause adverse effects in clinical signs, body weight development, clinical pathology, gross pathology, or histopathology in comparison to the vehicle‐control group. The no‐observed‐adverse‐effect‐level was determined to be 2550 mg/kg bw/day. These results add to the existing body of both preclinical and clinical work relevant to the safety of the extract and of interest to regulators in various global markets.
In recent times, extracts of mulberry leaves, which have long been consumed as food, have gained popularity. We have conducted a 90‐day oral toxicity study in rats of a purified Morus alba leaf extract standardized to contain 5 ± 0.5% 1‐deoxynojirimycin to add to past acute and subacute toxicological evaluations. No adverse effects were observed, and no target organs were identified following administration of 0 (vehicle control), 850, 1700, and 2550 mg/kg bw/day. The NOAEL was determined as 2550 mg/kg bw/day. |
|---|---|
| AbstractList | Mulberry (genus Morus) leaves have long been used as a human food, especially in Asia, and animal feed. More recently, mulberry leaf extracts have been introduced as a convenient way to consume mulberry for non-nutritional functional effects. Reducose® 5% is an Morus alba leaf extract that has been highly purified and standardized to a content of 5 ± 0.5% 1-deoxynojirimycin, a naturally present polyhydroxylated piperidine alkaloid analog of D-glucose. This extract has previously been evaluated in acute and subacute (28-day) oral toxicity studies in which no adverse effects of the test item were observed in mice or rats, respectively. Due to continued and growing interest in the extract in multinational markets, we have now further investigated potential toxic effects in subchronic (90-day) oral toxicity study in male and female Han:WIST rats. The test item was administered at doses of 850, 1700, and 2550 mg/kg bw/day, and did not cause adverse effects in clinical signs, body weight development, clinical pathology, gross pathology, or histopathology in comparison to the vehicle-control group. The no-observed-adverse-effect-level was determined to be 2550 mg/kg bw/day. These results add to the existing body of both preclinical and clinical work relevant to the safety of the extract and of interest to regulators in various global markets. Mulberry (genus Morus ) leaves have long been used as a human food, especially in Asia, and animal feed. More recently, mulberry leaf extracts have been introduced as a convenient way to consume mulberry for non‐nutritional functional effects. Reducose® 5% is an Morus alba leaf extract that has been highly purified and standardized to a content of 5 ± 0.5% 1‐deoxynojirimycin, a naturally present polyhydroxylated piperidine alkaloid analog of D‐glucose. This extract has previously been evaluated in acute and subacute (28‐day) oral toxicity studies in which no adverse effects of the test item were observed in mice or rats, respectively. Due to continued and growing interest in the extract in multinational markets, we have now further investigated potential toxic effects in subchronic (90‐day) oral toxicity study in male and female Han:WIST rats. The test item was administered at doses of 850, 1700, and 2550 mg/kg bw/day, and did not cause adverse effects in clinical signs, body weight development, clinical pathology, gross pathology, or histopathology in comparison to the vehicle‐control group. The no‐observed‐adverse‐effect‐level was determined to be 2550 mg/kg bw/day. These results add to the existing body of both preclinical and clinical work relevant to the safety of the extract and of interest to regulators in various global markets. In recent times, extracts of mulberry leaves, which have long been consumed as food, have gained popularity. We have conducted a 90‐day oral toxicity study in rats of a purified Morus alba leaf extract standardized to contain 5 ± 0.5% 1‐deoxynojirimycin to add to past acute and subacute toxicological evaluations. No adverse effects were observed, and no target organs were identified following administration of 0 (vehicle control), 850, 1700, and 2550 mg/kg bw/day. The NOAEL was determined as 2550 mg/kg bw/day. Mulberry (genus Morus) leaves have long been used as a human food, especially in Asia, and animal feed. More recently, mulberry leaf extracts have been introduced as a convenient way to consume mulberry for non-nutritional functional effects. Reducose® 5% is an Morus alba leaf extract that has been highly purified and standardized to a content of 5 ± 0.5% 1-deoxynojirimycin, a naturally present polyhydroxylated piperidine alkaloid analog of D-glucose. This extract has previously been evaluated in acute and subacute (28-day) oral toxicity studies in which no adverse effects of the test item were observed in mice or rats, respectively. Due to continued and growing interest in the extract in multinational markets, we have now further investigated potential toxic effects in subchronic (90-day) oral toxicity study in male and female Han:WIST rats. The test item was administered at doses of 850, 1700, and 2550 mg/kg bw/day, and did not cause adverse effects in clinical signs, body weight development, clinical pathology, gross pathology, or histopathology in comparison to the vehicle-control group. The no-observed-adverse-effect-level was determined to be 2550 mg/kg bw/day. These results add to the existing body of both preclinical and clinical work relevant to the safety of the extract and of interest to regulators in various global markets.Mulberry (genus Morus) leaves have long been used as a human food, especially in Asia, and animal feed. More recently, mulberry leaf extracts have been introduced as a convenient way to consume mulberry for non-nutritional functional effects. Reducose® 5% is an Morus alba leaf extract that has been highly purified and standardized to a content of 5 ± 0.5% 1-deoxynojirimycin, a naturally present polyhydroxylated piperidine alkaloid analog of D-glucose. This extract has previously been evaluated in acute and subacute (28-day) oral toxicity studies in which no adverse effects of the test item were observed in mice or rats, respectively. Due to continued and growing interest in the extract in multinational markets, we have now further investigated potential toxic effects in subchronic (90-day) oral toxicity study in male and female Han:WIST rats. The test item was administered at doses of 850, 1700, and 2550 mg/kg bw/day, and did not cause adverse effects in clinical signs, body weight development, clinical pathology, gross pathology, or histopathology in comparison to the vehicle-control group. The no-observed-adverse-effect-level was determined to be 2550 mg/kg bw/day. These results add to the existing body of both preclinical and clinical work relevant to the safety of the extract and of interest to regulators in various global markets. |
| Author | Hirka, Gábor Pasics Szakonyiné, Ilona Murbach, Timothy S. Endres, John R. Glávits, Róbert |
| Author_xml | – sequence: 1 givenname: Timothy S. orcidid: 0000-0002-7658-858X surname: Murbach fullname: Murbach, Timothy S. email: tim@aibmr.com organization: AIBMR Life Sciences, Inc – sequence: 2 givenname: Róbert surname: Glávits fullname: Glávits, Róbert organization: Toxi‐Coop Zrt – sequence: 3 givenname: John R. surname: Endres fullname: Endres, John R. organization: AIBMR Life Sciences, Inc – sequence: 4 givenname: Gábor surname: Hirka fullname: Hirka, Gábor organization: Toxi‐Coop Zrt – sequence: 5 givenname: Ilona surname: Pasics Szakonyiné fullname: Pasics Szakonyiné, Ilona organization: Toxi‐Coop Zrt |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38837228$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kc1qGzEUhUVJaZy0kCcIgmy6GVd_HmmWJvSXQDcpZCfuaKRERpYcaSaNd32EPmOfpIrzB6FdCV1951xxzgHaiylahI4omVNC2IcVjHPRCvEKzSjpuoaylu-hGWEtaQSXF_vooJQVIfWNqTdonyvFJWNqhsoSd-TPr98DbPEmWxN89AYCHtOtNymky93N3kCYYPQpYh9xhrHg5DDgK395Fapwyt55O2CIAzYpGhvHCtXBegq9zXmLgwWH7W0dm_Eteu0gFPvu4TxEPz59PD_90px9__z1dHnWGC460XSudcyIQTIA4wBE27e2l4IKxTjYjlK3UIIAp7QzRPYMFoNrASQ3zgGR_BC9v_fd5HQ92TLqtS_GhgDRpqloTtoFk5IJVdGTF-gqTTnW3-lqL8RCMUUqdfxATf3aDnqT_RryVj_G-bzR5FRKtu4JoUTfNaVrU_quqYrOX6DGj7uIa0Y-_EvQ3At--mC3_zXW35bnO_4v-9KlPQ |
| CitedBy_id | crossref_primary_10_3390_molecules30153213 |
| Cites_doi | 10.1021/jf0306901 10.1097/MD.0000000000011996 10.1371/journal.pone.0152728 10.1016/j.jep.2016.09.004 10.1021/jf071559m 10.1093/bbb/zbac011 10.1021/jf062680g 10.1007/s40292-015-0087-2 10.1177/0192623312438736 10.1021/jf9022228 10.3389/fmed.2022.904339 10.1016/j.clnesp.2022.03.027 10.3358/shokueishi.44.191 10.3390/nu14132674 10.4103/0973-1296.80683 10.1089/jmf.2014.3160 10.1007/BF00401402 10.1155/2012/735191 10.1201/b13783-10 10.1007/BF02976442 10.1002/ptr.3270 10.1177/1091581816670597 10.1371/journal.pone.0172239 10.1016/j.ctim.2017.04.006 10.1021/jf010567e 10.1293/tox.27.1S 10.3746/jfn.2007.12.2.119 10.1186/s12986-021-00571-2 10.1080/09637480600801837 10.1371/journal.pone.0288911 10.1016/j.yrtph.2018.03.007 10.1155/2018/2091872 10.1016/j.ctim.2019.102292 10.1293/tox.26.27S 10.1111/j.2040-1124.2011.00101.x |
| ContentType | Journal Article |
| Copyright | 2024 John Wiley & Sons Ltd. 2024 John Wiley & Sons, Ltd. |
| Copyright_xml | – notice: 2024 John Wiley & Sons Ltd. – notice: 2024 John Wiley & Sons, Ltd. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7ST 7TK 7U7 C1K K9. SOI 7X8 |
| DOI | 10.1002/jat.4644 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Environment Abstracts Neurosciences Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management ProQuest Health & Medical Complete (Alumni) Environment Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Toxicology Abstracts Neurosciences Abstracts Environment Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | MEDLINE ProQuest Health & Medical Complete (Alumni) CrossRef MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1099-1263 |
| EndPage | 1517 |
| ExternalDocumentID | 38837228 10_1002_jat_4644 JAT4644 |
| Genre | article Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: Phynova Group Limited, Banbury UK and Nestle Health Science, Vevey Switzerland – fundername: Phynova Group Limited, Banbury UK |
| GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 31~ 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AAHQN AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEFU ABEML ABIJN ABJNI ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AI. AIAGR AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BY8 CS3 D-E D-F DCZOG DPXWK DR2 DRFUL DRSTM EBD EBS EDH EJD F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA GWYGA H.T H.X HF~ HGLYW HHZ HVGLF HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M6Q MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG P2P P2W P2X P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ UB1 V8K VH1 W8V W99 WBFHL WBKPD WH7 WIB WIH WIK WJL WOHZO WQJ WRC WUP WWP WXSBR WYISQ XG1 XPP XV2 YCJ YHZ ZXP ZZTAW ~02 ~IA ~KM ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY AIQQE BANNL CITATION O8X CGR CUY CVF ECM EIF NPM 7ST 7TK 7U7 C1K K9. SOI 7X8 |
| ID | FETCH-LOGICAL-c3494-9f6f2c4d72aacfaa46b6eb7414823ae911f5840a3119c07b2a5df6aa73cffa073 |
| IEDL.DBID | DRFUL |
| ISICitedReferencesCount | 1 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001336680400013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0260-437X 1099-1263 |
| IngestDate | Sun Nov 09 13:31:34 EST 2025 Sat Nov 29 14:40:24 EST 2025 Thu Apr 03 07:03:45 EDT 2025 Sat Nov 29 07:06:50 EST 2025 Tue Nov 18 22:19:56 EST 2025 Wed Jan 22 17:16:04 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Keywords | toxicity DNJ 90‐day study NOAEL mulberry leaf extract, MLE 1‐deoxynojirimycin Reducose Morus alba OECD 408 |
| Language | English |
| License | 2024 John Wiley & Sons Ltd. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3494-9f6f2c4d72aacfaa46b6eb7414823ae911f5840a3119c07b2a5df6aa73cffa073 |
| Notes | Ilona Pasics Szakonyiné Senior Author ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-7658-858X |
| PMID | 38837228 |
| PQID | 3114458280 |
| PQPubID | 105373 |
| PageCount | 14 |
| ParticipantIDs | proquest_miscellaneous_3065277248 proquest_journals_3114458280 pubmed_primary_38837228 crossref_primary_10_1002_jat_4644 crossref_citationtrail_10_1002_jat_4644 wiley_primary_10_1002_jat_4644_JAT4644 |
| PublicationCentury | 2000 |
| PublicationDate | October 2024 2024-10-00 20241001 |
| PublicationDateYYYYMMDD | 2024-10-01 |
| PublicationDate_xml | – month: 10 year: 2024 text: October 2024 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Bognor Regis |
| PublicationSubtitle | JAT |
| PublicationTitle | Journal of applied toxicology |
| PublicationTitleAlternate | J Appl Toxicol |
| PublicationYear | 2024 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2013; 26 2013; 4 2012; 2012 2011; 2 2009; 20 2015; 18 2023; 18 2011 2006; 57 2014; 27 2009 1999; 22 2001; 49 2022; 86 2002 2024 2007; 55 2007; 12 2022; 49 2011; 7 2016; 35 1999 2016; 11 2004; 52 1968; 13 2009; 57 2012; 2 2018; 2018 2021; 18 2017; 32 2022; 9 2015; 22 2017; 12 2020; 49 2022; 14 2018 2018; 95 2014c 2014b 2011; 25 2013 2014a 2018; 97 2003; 44 2012; 40 2016; 194 e_1_2_8_28_1 e_1_2_8_29_1 e_1_2_8_47_1 Laddha G. (e_1_2_8_24_1) 2012; 2 e_1_2_8_25_1 e_1_2_8_46_1 e_1_2_8_26_1 e_1_2_8_49_1 e_1_2_8_27_1 e_1_2_8_48_1 e_1_2_8_5_1 e_1_2_8_4_1 Hard G. (e_1_2_8_13_1) 1999 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_43_1 e_1_2_8_21_1 e_1_2_8_42_1 e_1_2_8_22_1 e_1_2_8_45_1 e_1_2_8_23_1 e_1_2_8_44_1 Aditya Rao S. (e_1_2_8_3_1) 2013; 4 e_1_2_8_41_1 e_1_2_8_40_1 e_1_2_8_17_1 Abdulla M. (e_1_2_8_2_1) 2009; 20 e_1_2_8_18_1 e_1_2_8_39_1 FAO (e_1_2_8_10_1) 2002 e_1_2_8_19_1 e_1_2_8_35_1 e_1_2_8_15_1 e_1_2_8_38_1 e_1_2_8_16_1 e_1_2_8_37_1 e_1_2_8_32_1 e_1_2_8_31_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_12_1 Haschek W. (e_1_2_8_14_1) 2009 e_1_2_8_33_1 e_1_2_8_30_1 OECD (e_1_2_8_36_1) 2018 |
| References_xml | – volume: 18 start-page: 306 year: 2015 end-page: 313 article-title: Mulberry leaf extract improves postprandial glucose response in prediabetic subjects: A randomized, double‐blind placebo‐controlled trial publication-title: Journal of Medicinal Food – year: 2011 – volume: 12 year: 2017 article-title: Mulberry‐extract improves glucose tolerance and decreases insulin concentrations in normoglycaemic adults: Results of a randomised double‐blind placebo‐controlled study publication-title: PLoS ONE – year: 2009 – volume: 55 start-page: 5869 year: 2007 end-page: 5874 article-title: Food‐grade mulberry powder enriched with 1‐deoxynojirimycin suppresses the elevation of postprandial blood glucose in humans publication-title: Journal of Agricultural and Food Chemistry – volume: 7 start-page: 171 year: 2011 end-page: 175 article-title: Evaluation of cytotoxicity and genotoxicity of some Philippine medicinal plants publication-title: Pharmacognosy Magazine – volume: 44 start-page: 191 year: 2003 end-page: 197 article-title: Ninety‐day dietary toxicity study of mulberry leaf extract in rats [English translation] publication-title: Shokuhin Eiseigaku Zasshi – start-page: 209 year: 2013 end-page: 254 – year: 2014c – volume: 32 start-page: 105 year: 2017 end-page: 108 article-title: Impact of mulberry leaf extract on type 2 diabetes (Mul‐DM): A randomized, placebo‐controlled pilot study publication-title: Complementary Therapies in Medicine – volume: 2018 start-page: 1 year: 2018 end-page: 11 article-title: A double‐blind placebo‐controlled randomized trial evaluating the effect of polyphenol‐rich herbal congee on bone turnover markers of the perimenopausal and menopausal women publication-title: Oxidative Medicine and Cellular Longevity – volume: 35 start-page: 683 year: 2016 end-page: 691 article-title: A 28‐day repeated dose toxicological study of an aqueous extract of L publication-title: International Journal of Toxicology – year: 2014a – volume: 194 start-page: 162 year: 2016 end-page: 168 article-title: Evaluation of acute toxicity, genotoxicity and inhibitory effect on acute inflammation of an ethanol extract of L. (Moraceae) in mice publication-title: Journal of Ethnopharmacology – year: 2024 – volume: 49 year: 2020 article-title: A randomized controlled study of dose‐finding, efficacy, and safety of mulberry leaves on glycemic profiles in obese persons with borderline diabetes publication-title: Complementary Therapies in Medicine – start-page: 1 year: 1999 end-page: 32 – volume: 20 start-page: 35 year: 2009 end-page: 39 article-title: Evaluation of the anti‐ulcer activities of extracts in experimentally‐induced gastric ulcer in rats publication-title: Biomedical Research – volume: 13 start-page: 222 year: 1968 end-page: 257 article-title: Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse publication-title: Psychopharmacologia – volume: 95 start-page: 220 year: 2018 end-page: 226 article-title: Safety evaluation of mulberry leaf extract: Acute, subacute toxicity and genotoxicity studies publication-title: Regulatory Toxicology and Pharmacology – volume: 18 year: 2021 article-title: Mulberry leaf extract improves glycaemic response and insulaemic response to sucrose in healthy subjects: Results of a randomized, double blind, placebo‐controlled study publication-title: Nutrition & Metabolism (London) – volume: 57 start-page: 305 year: 2006 end-page: 313 article-title: Nutritional quality of leaves of some genotypes of mulberry ( ) publication-title: International Journal of Food Sciences and Nutrition – volume: 12 start-page: 119 year: 2007 end-page: 121 article-title: Tyrosinase inhibition and mutagenicity of phenolic compounds from mulberry leaves – research note publication-title: Preventive Nutrition and Food Science – year: 2018 – volume: 11 year: 2016 article-title: Prevention effects and possible molecular mechanism of mulberry leaf extract and its formulation on rats with insulin‐insensitivity publication-title: PLoS ONE – volume: 26 start-page: 27S year: 2013 end-page: 57S article-title: Proliferative and non‐proliferative lesions of the rat and mouse integument publication-title: Journal of Toxicologic Pathology – volume: 4 start-page: 822 year: 2013 end-page: 830 article-title: Evaluation of anti‐inflammatory and analgesic activity in three species publication-title: Research Journal of Pharmaceutical, Biological and Chemical Sciences – volume: 55 start-page: 8928 year: 2007 end-page: 8933 article-title: Occurrence of orally administered mulberry 1‐deoxynojirimycin in rat plasma publication-title: Journal of Agricultural and Food Chemistry – volume: 25 start-page: 365 year: 2011 end-page: 369 article-title: Efficacy of mulberry leaf tablets in patients with mild dyslipidemia publication-title: Phytotherapy Research – volume: 22 start-page: 149 year: 2015 end-page: 154 article-title: Effects of a new combination of nutraceuticals with on lipid profile, insulin sensitivity and endothelial function in dyslipidemic subjects. A cross‐over, randomized, double‐blind trial publication-title: High Blood Pressure & Cardiovascular Prevention – volume: 86 start-page: 519 year: 2022 end-page: 527 article-title: Safety evaluation of a beverage containing mulberry leaf extract publication-title: Bioscience, Biotechnology, and Biochemistry – volume: 22 start-page: 81 year: 1999 end-page: 85 article-title: Antioxidative flavonoids from the leaves of publication-title: Archives of Pharmacal Research – volume: 49 start-page: 68 year: 2022 end-page: 73 article-title: Morus Alba leaf extract affects metabolic profiles, biomarkers inflammation and oxidative stress in patients with type 2 diabetes mellitus: A double‐blind clinical trial publication-title: Clinical Nutrition ESPEN – volume: 40 start-page: 14S year: 2012 end-page: 86S article-title: Proliferative and nonproliferative lesions of the rat and mouse urinary system publication-title: Toxicologic Pathology – volume: 9 year: 2022 article-title: 13C‐sucrose breath test for the non‐invasive assessment of environmental enteropathy in Zambian adults publication-title: Frontiers in Medicine – volume: 2 start-page: 318 year: 2011 end-page: 323 article-title: Effect of mulberry leaf extract with enriched 1‐deoxynojirimycin content on postprandial glycemic control in subjects with impaired glucose metabolism publication-title: Journal of Diabetes Investigation – volume: 52 start-page: 1415 year: 2004 end-page: 1418 article-title: Determination of 1‐deoxynojirimycin in mulberry leaves using hydrophilic interaction chromatography with evaporative light scattering detection publication-title: Journal of Agricultural and Food Chemistry – year: 2014b – volume: 49 start-page: 4208 year: 2001 end-page: 4213 article-title: Polyhydroxylated alkaloids isolated from mulberry trees ( L.) and silkworms ( L.) publication-title: Journal of Agricultural and Food Chemistry – year: 2002 – volume: 2 start-page: 513 year: 2012 end-page: 519 article-title: Anti‐psychotic effect of aqueous leaves extract of in animal models publication-title: International Journal of Pharmacy – volume: 27 start-page: 1S year: 2014 end-page: 107S article-title: Nonproliferative and proliferative lesions of the rat and mouse female reproductive system publication-title: Journal of Toxicologic Pathology – volume: 14 year: 2022 article-title: Effect of different nutritional supplements on glucose response of complete meals in two crossover studies publication-title: Nutrients – volume: 2012 year: 2012 article-title: A six‐month supplementation of mulberry, Korean red ginseng, and banaba decreases biomarkers of systemic low‐grade inflammation in subjects with impaired glucose tolerance and type 2 diabetes publication-title: Evidence‐Based Complementary and Alternative Medicine – volume: 18 year: 2023 article-title: The impact of mulberry leaf extract at three different levels on reducing the glycemic index of white bread publication-title: PLoS ONE – volume: 97 year: 2018 article-title: Mulberry leaf extract reduces the glycemic indexes of four common dietary carbohydrates publication-title: Medicine (Baltimore) – volume: 57 start-page: 9133 year: 2009 end-page: 9140 article-title: Phytochemical profiles of different mulberry ( sp.) species from China publication-title: Journal of Agricultural and Food Chemistry – ident: e_1_2_8_22_1 doi: 10.1021/jf0306901 – ident: e_1_2_8_47_1 doi: 10.1097/MD.0000000000011996 – ident: e_1_2_8_26_1 doi: 10.1371/journal.pone.0152728 – ident: e_1_2_8_37_1 doi: 10.1016/j.jep.2016.09.004 – ident: e_1_2_8_31_1 doi: 10.1021/jf071559m – ident: e_1_2_8_49_1 doi: 10.1093/bbb/zbac011 – ident: e_1_2_8_21_1 doi: 10.1021/jf062680g – ident: e_1_2_8_45_1 doi: 10.1007/s40292-015-0087-2 – ident: e_1_2_8_11_1 doi: 10.1177/0192623312438736 – ident: e_1_2_8_40_1 doi: 10.1021/jf9022228 – ident: e_1_2_8_39_1 doi: 10.3389/fmed.2022.904339 – ident: e_1_2_8_42_1 doi: 10.1016/j.clnesp.2022.03.027 – ident: e_1_2_8_30_1 doi: 10.3358/shokueishi.44.191 – ident: e_1_2_8_12_1 doi: 10.3390/nu14132674 – ident: e_1_2_8_33_1 – ident: e_1_2_8_7_1 doi: 10.4103/0973-1296.80683 – ident: e_1_2_8_18_1 doi: 10.1089/jmf.2014.3160 – ident: e_1_2_8_32_1 – volume-title: Mulberry for animal production: Proceedings of an electronic conference carried out between May and August 2000 year: 2002 ident: e_1_2_8_10_1 – volume-title: OECD guidelines for the testing of chemicals, section 4 year: 2018 ident: e_1_2_8_36_1 – ident: e_1_2_8_15_1 doi: 10.1007/BF00401402 – ident: e_1_2_8_17_1 doi: 10.1155/2012/735191 – ident: e_1_2_8_16_1 doi: 10.1201/b13783-10 – ident: e_1_2_8_19_1 doi: 10.1007/BF02976442 – ident: e_1_2_8_4_1 doi: 10.1002/ptr.3270 – volume: 4 start-page: 822 year: 2013 ident: e_1_2_8_3_1 article-title: Evaluation of anti‐inflammatory and analgesic activity in three Morus species publication-title: Research Journal of Pharmaceutical, Biological and Chemical Sciences – ident: e_1_2_8_28_1 doi: 10.1177/1091581816670597 – ident: e_1_2_8_35_1 – ident: e_1_2_8_46_1 – volume: 20 start-page: 35 year: 2009 ident: e_1_2_8_2_1 article-title: Evaluation of the anti‐ulcer activities of Morus alba extracts in experimentally‐induced gastric ulcer in rats publication-title: Biomedical Research – ident: e_1_2_8_27_1 doi: 10.1371/journal.pone.0172239 – ident: e_1_2_8_38_1 doi: 10.1016/j.ctim.2017.04.006 – ident: e_1_2_8_6_1 doi: 10.1021/jf010567e – ident: e_1_2_8_9_1 doi: 10.1293/tox.27.1S – ident: e_1_2_8_20_1 doi: 10.3746/jfn.2007.12.2.119 – ident: e_1_2_8_44_1 doi: 10.1186/s12986-021-00571-2 – ident: e_1_2_8_41_1 doi: 10.1080/09637480600801837 – ident: e_1_2_8_23_1 – ident: e_1_2_8_8_1 doi: 10.1371/journal.pone.0288911 – volume: 2 start-page: 513 year: 2012 ident: e_1_2_8_24_1 article-title: Anti‐psychotic effect of aqueous leaves extract of Morus alba in animal models publication-title: International Journal of Pharmacy – ident: e_1_2_8_25_1 doi: 10.1016/j.yrtph.2018.03.007 – volume-title: Gastrointestinal system: Diaphragmatic hernia, fundamentals of toxicologic pathology year: 2009 ident: e_1_2_8_14_1 – ident: e_1_2_8_48_1 doi: 10.1155/2018/2091872 – start-page: 1 volume-title: Guides for toxicologic pathology year: 1999 ident: e_1_2_8_13_1 – ident: e_1_2_8_43_1 doi: 10.1016/j.ctim.2019.102292 – ident: e_1_2_8_29_1 doi: 10.1293/tox.26.27S – ident: e_1_2_8_5_1 doi: 10.1111/j.2040-1124.2011.00101.x – ident: e_1_2_8_34_1 |
| SSID | ssj0009928 |
| Score | 2.4048264 |
| Snippet | Mulberry (genus Morus) leaves have long been used as a human food, especially in Asia, and animal feed. More recently, mulberry leaf extracts have been... Mulberry (genus Morus ) leaves have long been used as a human food, especially in Asia, and animal feed. More recently, mulberry leaf extracts have been... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1504 |
| SubjectTerms | 1-Deoxynojirimycin - analogs & derivatives 1-Deoxynojirimycin - toxicity 1‐deoxynojirimycin 90‐day study Administration, Oral Animal feed Animals Body weight Body Weight - drug effects DNJ Dose-Response Relationship, Drug Feeds Female Global marketing Histopathology Leaves Male Morus - chemistry Morus alba mulberry leaf extract, MLE No-Observed-Adverse-Effect Level NOAEL OECD 408 Organ Size - drug effects Pathology Piperidine Plant extracts Plant Extracts - toxicity Plant Leaves - chemistry Rats Rats, Wistar Reducose Side effects Toxicity Toxicity testing Toxicity Tests, Subchronic Toxicology |
| Title | A 90‐day preclinical toxicological evaluation in rats of a highly purified and concentrated mulberry leaf extract |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjat.4644 https://www.ncbi.nlm.nih.gov/pubmed/38837228 https://www.proquest.com/docview/3114458280 https://www.proquest.com/docview/3065277248 |
| Volume | 44 |
| WOSCitedRecordID | wos001336680400013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1099-1263 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0009928 issn: 0260-437X databaseCode: DRFUL dateStart: 19960101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JaxRBFH6YiQchuMQlozE8QcZLOulUVy91DOrgIYRBEplb87oWGBl7wvSMODd_gr_RX-KrXqYJKgie-lCvuoqqt3y1vK8AXhslhSiKODA24QVKkqhAZVIHUgnrwtiGSX0Z89NFenmZTadq0t6q9LkwDT_EdsPNW0btr72BU1Gd9qShn2l1Ijma78CuYLWNB7D77uP4-qKn3FX1y6qeNCuQUTrtqGdDcdrVvR2MfkOYtwFrHXHGD_6nrw_hfosz8bxRjEdwx5b7MJo0RNWbY7zq866qYxzhpKew3uzDXrObh02S0mOozlGFP7__MLTBG_aRbTolrhbfZrpzn9gzh-OsRFatChcOCT0l8pwrrpczx4gXqTSofbpkWVPjGvyy9kxbyw3OLTnkcOFTt57A9fj91dsPQftcQ6A9x02gXOKEliYVRNoRyaRIbMGIRWYiIste1THaCSk6O1M6TAtBsXEJURpp54hdzVMYlIvSHgCScqJgKMLRU0tbUGYoloV1RlsnY5sM4U03b7luucz9kxrzvGFhFjmPeO5HfAivtpI3DX_HH2QOu6nPWwuucu6lrM8UQ_7Ftphtzx-oUGkXa5Zh_CZ4eSKzITxrVGbbSJTx0l8ILhnVmvHX1nP2w_77_F8FX8A9wciquVF4CIPVcm1fwl39dTWrlkewk06zo9YWfgGoAQ7O |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bixMxFD6su4KCeFlXra56BKkvO-5sJnMJPi1qWbGWIl3p23Amk0ClTpdOK_bNn-Bv9Jd4MpcOiwqCT_OQk0lIzuXL5XwBeJ4rKUSWhV5uIl6gRJHyVCK1J5Uw1g-NH1WXMT8N49EomU7VeAdetbkwNT_EdsPNWUblr52Buw3p44419DOtXkoO51dgT7IWsXrvvfk4OB92nLuqelrVsWZ5MoinLfesL47bupej0W8Q8zJirULO4NZ_dfY23GyQJp7WqnEHdkyxD_1xTVW9OcJJl3lVHmEfxx2J9WYfbtT7eVinKd2F8hSV__P7j5w2eMFeskmoxNXi20y3DhQ77nCcFcjKVeLCIqEjRZ5zxfVyZhnzIhU5apcwWVTkuDl-WTuureUG54YscsBwyVsHcD54O3l95jUPNnjasdx4ykZWaJnHgkhbIhllkckYs8hEBGTYr1rGOz4FJydK-3EmKMxtRBQH2lpiZ3MPdotFYR4AkrIiYzDC8VNLk1GSUygzY3NtrAxN1IMX7cSlumEzd49qzNOah1mkPOKpG_EePNtKXtQMHn-QOWznPm1suEy5l7I6VfT5F9titj53pEKFWaxZhhGc4AWKTHpwv9aZbSNBwot_IbikX6nGX1tP2RO778N_FXwK184mH4bp8N3o_SO4Lhhn1fcLD2F3tVybx3BVf13NyuWTxiR-AWpoEdY |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bixMxFD6sXRFBvKy36qpHkPqy485mMpkJPi2uRbGUIrvStyGTC1TqtHRasW_-BH-jv8STuXRYVBB8mockk5Ccy5fL-Q7ACyM5Y3keB8YK2qAIIQOZch1wyawLYxuK6jHmp1EyHqfTqZzswes2Fqbmh9gduHnNqOy1V3C7NO64Yw39rNavOLnzK7DPfQ6ZHuyffRxejDrOXVmlVvWsWQGPkmnLPRuy47btZW_0G8S8jFgrlzO89V-DvQ03G6SJp7Vo3IE9WxzAYFJTVW-P8LyLvCqPcICTjsR6ewA36vM8rMOU7kJ5ijL8-f2HUVtckpVsAipxvfg2060BxY47HGcFknCVuHCo0JMiz6nhZjVzhHlRFQa1D5gsKnJcg182nmtrtcW5VQ7JYfjgrXtwMXx7_uZd0CRsCLRnuQmkE45pbhKmlHZKcZELmxNm4SmLlCW76gjvhCo6OZE6THKmYuOEUkmknVNkbO5Dr1gU9iGgko7lBEbIf2puc5UaFfPcOqOt47EVfXjZLlymGzZzn1RjntU8zCyjGc_8jPfh-a7msmbw-EOdw3bts0aHy4xGyatbxZB-sSsm7fNXKqqwiw3VIQTHaIPC0z48qGVm10mU0uafMSoZVKLx194zssT---hfKz6Da5OzYTZ6P_7wGK4zgln188JD6K1XG_sEruqv61m5etpoxC_dAhFR |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+90-day+preclinical+toxicological+evaluation+in+rats+of+a+highly+purified+and+concentrated+mulberry+leaf+extract&rft.jtitle=Journal+of+applied+toxicology&rft.au=Murbach%2C+Timothy+S&rft.au=Gl%C3%A1vits%2C+R%C3%B3bert&rft.au=Endres%2C+John+R&rft.au=Hirka%2C+G%C3%A1bor&rft.date=2024-10-01&rft.issn=1099-1263&rft.eissn=1099-1263&rft.volume=44&rft.issue=10&rft.spage=1504&rft_id=info:doi/10.1002%2Fjat.4644&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0260-437X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0260-437X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0260-437X&client=summon |